Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in …
…, AS Dzharullaeva, AV Kovyrshina, NL Lubenets… - The Lancet, 2021 - thelancet.com
Background A heterologous recombinant adenovirus (rAd)-based vaccine, Gam-COVID-Vac
(Sputnik V), showed a good safety profile and induced strong humoral and cellular immune …
(Sputnik V), showed a good safety profile and induced strong humoral and cellular immune …
Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1 …
…, YV Simakova, EA Tokarskaya, NL Lubenets… - The Lancet, 2020 - thelancet.com
Background We developed a heterologous COVID-19 vaccine consisting of two components,
a recombinant adenovirus type 26 (rAd26) vector and a recombinant adenovirus type 5 (…
a recombinant adenovirus type 26 (rAd26) vector and a recombinant adenovirus type 5 (…
[HTML][HTML] An open, non-randomised, phase 1/2 trial on the safety, tolerability, and immunogenicity of single-dose vaccine “Sputnik Light” for prevention of coronavirus …
…, AV Kovyrshina, NL Lubenets… - The Lancet Regional …, 2021 - thelancet.com
Background While the world is experiencing another wave of COVID-19 pandemic, global
vaccination program is hampered by an evident shortage in the supply of licensed vaccines. …
vaccination program is hampered by an evident shortage in the supply of licensed vaccines. …
Safety and immunogenicity of rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine against SARS-CoV-2 in healthy adolescents: an open-label …
…, EA Tokarskaya, NA Nikitenko, NL Lubenets… - Frontiers in …, 2023 - frontiersin.org
To protect young individuals against SARS-CoV-2 infection, we conducted an open-label,
prospective, non-randomised dose-escalation Phase 1/2 clinical trial to evaluate the …
prospective, non-randomised dose-escalation Phase 1/2 clinical trial to evaluate the …
One-shot immunization with Sputnik Light (the first component of Sputnik V vaccine) is effective against SARS-CoV-2 Delta variant: efficacy data on the use of the …
…, AS Dzharullaeva, AV Kovyrshina, NL Lubenets… - medRxiv, 2021 - medrxiv.org
Objectives Vaccination remains the most effective response to the COVID-19 pandemic. Most
vaccines use two-dose regimens. In turn, single-dose vaccines also have high potential, …
vaccines use two-dose regimens. In turn, single-dose vaccines also have high potential, …
An open, non-randomised, 1/2 phase study on the safety, tolerability, and immunogenicity of single dose'Sputnik light'vaccine for prevention of coronavirus infection in …
…, AS Dzharullaeva, AV Kovyrshina, NL Lubenets… - 2021 - papers.ssrn.com
Background: While the world is experiencing another wave of COVID-19 pandemic, global
vaccination program is hampered by obvious shortage in supply of licensed vaccines. …
vaccination program is hampered by obvious shortage in supply of licensed vaccines. …
“Who's the fairest of them all?” Beauty and Femininity in Contemporary Russian Adolescent Girl Fiction
L Rudova - The Russian Review, 2014 - Wiley Online Library
The present article draws attention to “post‐Soviet commodity tales,” a subgenre of adolescent
girl fiction that provides a narrative of personal success for girls willing to learn the tricks …
girl fiction that provides a narrative of personal success for girls willing to learn the tricks …
Efficacy of a nasal spray containing Iota-Carrageenan in the prophylaxis of COVID-19 in hospital personnel dedicated to patients care with COVID-19 disease A …
JM Figueroa, M Lombardo, A Dogliotti, LP Flynn… - medRxiv, 2021 - medrxiv.org
Background Iota-Carrageenan (IC) is a sulfate polysaccharide synthesized by red algae,
with demonstrated antiviral activity and clinical efficacy as nasal spray in the treatment of …
with demonstrated antiviral activity and clinical efficacy as nasal spray in the treatment of …
4H-[1, 3, 4]-THIADIAZIN-2-(2, 4-DIFLUOROPHENYL) CARBOXAMIDE IN CRYSTALLINE FORM, AND USE THEREOF AS ANTIBACTERIAL AGENT FOR TREATING …
ZNA RU, LNL RU, ZES RU, LSI RU, SAB RU… - Journal of …, 2016 - elibrary.ru
(57) Abstract: FIELD: medicine; pharmaceuticals. SUBSTANCE: invention relates to a
pharmaceutical composition of antibacterial action, comprising active substance 4-(3-ethoxy-4-…
pharmaceutical composition of antibacterial action, comprising active substance 4-(3-ethoxy-4-…
[PDF][PDF] CREATION AND ASSESSMENT OF BREEDING MATERIAL OF LUCERNE WITH THE HEIGHTENED LEVEL OF AZOTFIXATION
R Vozhehova, O Tyshchenko - agrovisnyk.com
… selection, according to the classification by PO Lubenets. Basically it is alfalfa of sowing type
… two peaks in the hybrids Sitel / Nadezhda F2 and Gloria / Nadezhda F2 by the distribution of …
… two peaks in the hybrids Sitel / Nadezhda F2 and Gloria / Nadezhda F2 by the distribution of …
